The global structural heart device market is expected to reach $9.7 billion by 2022

   March 27, 2017
According to a new market report published by Lucintel, the future of the global structural heart device market looks promising with opportunities in public and private hospitals. The global structural heart device market is expected to reach an estimated $9.7 billion by 2022 and it is forecast to grow at a CAGR of 14.3% from 2017 to 2022. The major drivers for market growth are growing demand for minimally invasive surgery, growing healthcare expenditure, and a growing geriatric population.

Browse 34 market data tables and 84 figures spread through 145 pages and in-depth TOC on “Global Structural Heart Device Market”

In this market, annuloplasty, valvuloplasty, trans catheter mitral valve repair (TMVR), surgical heart valve, and trans catheter aortic valve replacement (TAVR) are the main segments by procedure type. On the basis of comprehensive research, Lucintel forecasts that the TAVR, TMVR, and tissue heart valve segments are expected to show above average growth during the forecast period.

Within the global structural heart device market, the TAVR segment is expected to remain the largest segment. Increased catheter based procedures coupled with rising adoption of technological advancements in an effort to reduce treatment duration for high conventional surgical risk patients is expected to result in significant growth of the trans catheter aortic valve replacement market.

Download Free PDF Brochure @

By position of structural heart device, aorta is expected to remain the largest segment as patients commonly suffer from severe aortic stenosis considered as high risk for surgery.

North America is expected to remain the largest market and is expected to witness the highest growth rate during the forecast period mainly due to increasing adoption of minimally invasive procedures for heart valve repair and replacement in this region.

For business expansion, Lucintel’s report suggests technological advancement and new product development to achieve low risk and faster recovery.

Pre-Purchase Query @

Emerging trends which have a direct impact on the dynamics of the industry include rising adoption of transcatheter aortic valve replacement procedure and introduction of new hybrid tissue engineered heart valve. Edwards Lifesciences Corporation, Medtronic Public Limited Company, St. Jude Medical, Inc, Boston Scientific Corporation, and LivaNova PLC are among the major suppliers of structural heart devices.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global structural heart device market by procedure, position, and region, and has compiled a comprehensive research report entitled “Growth Opportunities in the Global Structural Heart Device Market 2017-2022: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a springboard for growth strategy by providing comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the global structural heart device market by procedure, position, and region, as follows:

Structural heart device market by procedure [Value ($ Million) from 2011 to 2022]:

  • Repair

    • Annuloplasty

    • Valvuloplasty

    • Transcatheter Mitral Valve Repair (TMVR)

    • Repair Other

  • Replacement

    • Surgical Valve

      • Mechanical Heart Valve

      • Tissue Heart Valve

    • Transcatheter Aortic Valve Replacement (TAVR)

Structural heart device market by position [Value ($ Million) from 2011 to 2022]:

  • Aorta

  • Mitral

  • Other

Structural heart device market by region [Value ($ Million) from 2011 to 2022]:

  • North America

  • Europe

  • APAC

  • ROW

Download Free Sample Page @

This 145-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link or

 About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Market Research Reports

Aerospace & Defense [53]
Chemical [264]
Composites & Advanced Materials [171]
Construction & Industrial [76]
Consumer and Retail [140]
Economic Analysis [86]
Energy & Utility [73]
Finance & Services [10]
Healthcare [79]
Media & Entertainment [16]
Metals & Mining [17]
Technology & Telecommunication [166]
Transportation [143]

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti

Quick Query

Lucintel Insights in News

Follow us on